Omeprazol Biofarm (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Biofarm, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and ulcer prophylaxis in patients taking NSAIDs.

GNH USA supplies Omeprazol Biofarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and reduces recurrence. - NSAID‑induced ulcer prophylaxis: lowers risk of ulcer formation in patients on non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics.

Adverse reactions may occur with Omeprazol Biofarm use.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools without blood. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort in the stomach area. - Flatulence: excess gas causing bloating. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmia. - Elevated liver enzymes: possible hepatic inflammation. - Stevens‑Johnson syndrome: serious skin reaction with blistering. - Interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before initiating therapy, consider the following safety measures. - Renal function assessment: evaluate kidney status, especially in patients with chronic kidney disease. - Magnesium monitoring: check serum magnesium during prolonged use. - Hepatic impairment caution: use with care in patients with liver disease. - Hypersensitivity avoidance: do not use if known allergy to omeprazole or other PPIs. - Elderly dose consideration: start with the lowest effective dose in older adults. - Store at ambient temperature: keep in the original pack, protect from moisture.

Omeprazol Biofarm may alter the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, leading to subtherapeutic antiviral levels. - Methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer anticoagulation monitoring. - Diazepam: elevated serum concentrations, may enhance sedation. - Digoxin: potential rise in digoxin levels, necessitating therapeutic drug monitoring.